Home › Targets › IL-2Rβ

IL-2Rβ (1 companies · 4 programs)

Companies with an active program directed at IL-2Rβ.

Medicenna Therapeutics Corp. MDNAF

MDNA11 — Solid Tumors Phase 1
MDNA19 Preclinical
MDNA223 Preclinical
MDNA209 Preclinical